EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of linezolid on platelet count in critically ill patients with thrombocytopenia

Hiroomi Tatsumi iD, Masayuki Akatsuka, Hiromitsu Kuroda iD, Satoshi Kazuma, Shintaro Suzuki, Yoshiki Masuda

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Hiroomi Tatsumi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Thrombocytopenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Linezolid (LZD) is one of the antibiotics used to treat methicillin-resistant Staphylococcus aureus . In Japan, the dose of LZD is not generally adjusted by renal function or therapeutic drug monitoring and is readily available for critically ill patients. The adverse effects of LZD include pancytopenia, especially thrombocytopenia. We investigated the effect of LZD on platelet counts in critically ill patients with thrombocytopenia during admission to the intensive care unit (ICU).

Methods

Fifty-five critically ill patients with existing thrombocytopenia (platelet count < 100 ×10 3 /μL) who received LZD for five days or more during the period from January 2011 to October 2018 were included. Changes in platelet count and frequency of platelet concentrate (PC) transfusion were evaluated retrospectively.

Results

Mean (± standard error) platelet count prior to initiation of LZD was 47 ± 4 ×10 3 /uL, which increased significantly to 86 ± 13 ×10 3 /uL on day 15 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusThrombocytopeniaHumansPlatelet CountLinezolidCritical IllnessRetrospective Studies

Substanzen

Linezolid

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.

ORCID-Profile: Hiroomi Tatsumi, Hiromitsu Kuroda

Zitieren

APA

Tatsumi, H., Akatsuka, M., Kuroda, H., Kazuma, S., Suzuki, S., & Masuda, Y. (2023). Effect of linezolid on platelet count in critically ill patients with thrombocytopenia. PLOS ONE. https://doi.org/10.1371/journal.pone.0286088

Vancouver

Tatsumi H, Akatsuka M, Kuroda H, Kazuma S, Suzuki S, Masuda Y. Effect of linezolid on platelet count in critically ill patients with thrombocytopenia. PLOS ONE. 2023. doi:10.1371/journal.pone.0286088

BibTeX
@article{Tatsumi2023,
  author = {Tatsumi, Hiroomi and Akatsuka, Masayuki and Kuroda, Hiromitsu and Kazuma, Satoshi and Suzuki, Shintaro and Masuda, Yoshiki},
  title = {Effect of linezolid on platelet count in critically ill patients with thrombocytopenia},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286088}
}
Kostenlos starten →